These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23396295)
1. Utility of OCT3/4, TSPY and β-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads. Palma I; Garibay N; Pena-Yolanda R; Contreras A; Raya A; Dominguez C; Romero M; Aristi G; Queipo G Dis Markers; 2013; 34(6):419-24. PubMed ID: 23396295 [TBL] [Abstract][Full Text] [Related]
2. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY. Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444 [TBL] [Abstract][Full Text] [Related]
3. Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant transformation. Palma I; Peña RY; Contreras A; Ceballos-Reyes G; Coyote N; Eraña L; Kofman-Alfaro S; Queipo G Cancer Lett; 2008 May; 263(2):204-11. PubMed ID: 18295396 [TBL] [Abstract][Full Text] [Related]
4. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118 [TBL] [Abstract][Full Text] [Related]
6. Tumor risk in disorders of sex development (DSD). Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas. Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135 [TBL] [Abstract][Full Text] [Related]
8. Undetectable anti-Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis. Hannema SE; Wolffenbuttel KP; van Bever Y; Brüggenwirth HT; van den Berg SAA; Hersmus R; Oosterhuis JW; Looijenga LHJ Clin Endocrinol (Oxf); 2023 Jul; 99(1):58-63. PubMed ID: 36905105 [TBL] [Abstract][Full Text] [Related]
9. 46 XY pure gonadal dysgenesis with gonadoblastoma and dysgerminoma. Ben Temime R; Chachial A; Attial L; Ghodbanel I; Makhloufl T; Koubaal A; Kourda N; Ben Jilani S; Dammak T; El May A; Rahal K Tunis Med; 2008 Jul; 86(7):710-3. PubMed ID: 19472738 [TBL] [Abstract][Full Text] [Related]
10. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients. Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751 [TBL] [Abstract][Full Text] [Related]
11. Canine ovarian gonadoblastoma with dysgerminoma overgrowth: a case study and literature review. Flores AR; Lobo J; Nunes F; Rêma A; Lopes P; Carvalho L; Bartosch C; Amorim I; Gärtner F J Ovarian Res; 2019 Sep; 12(1):89. PubMed ID: 31547830 [TBL] [Abstract][Full Text] [Related]
12. Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome. Joki-Erkkilä MM; Karikoski R; Rantala I; Lenko HL; Visakorpi T; Heinonen PK J Pediatr Adolesc Gynecol; 2002 Jun; 15(3):145-9. PubMed ID: 12106750 [TBL] [Abstract][Full Text] [Related]
13. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy. Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272 [TBL] [Abstract][Full Text] [Related]
14. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads. Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684 [TBL] [Abstract][Full Text] [Related]
15. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819 [TBL] [Abstract][Full Text] [Related]
16. Coexistence of gonadoblastoma and dysgerminoma in a dysgenetic gonad on touch preparation: a case report. Maleki Z; Loveless M; Fraig M Diagn Cytopathol; 2011 Jan; 39(1):42-4. PubMed ID: 21162092 [TBL] [Abstract][Full Text] [Related]
17. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Li Y; Vilain E; Conte F; Rajpert-De Meyts E; Lau YF Urol Oncol; 2007; 25(2):141-6. PubMed ID: 17349529 [TBL] [Abstract][Full Text] [Related]
18. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. Honecker F; Kersemaekers AM; Molier M; Van Weeren PC; Stoop H; De Krijger RR; Wolffenbuttel KP; Oosterhuis W; Bokemeyer C; Looijenga LH J Pathol; 2004 Oct; 204(2):167-74. PubMed ID: 15378486 [TBL] [Abstract][Full Text] [Related]
19. Expression of SALL4 and SF-1 in gonadoblastoma: useful markers in the identification of the invasive germ cell component. Bai S; Wei S; Ziober A; Yao Y; Bing Z Int J Gynecol Pathol; 2013 Jul; 32(4):379-83. PubMed ID: 23722510 [TBL] [Abstract][Full Text] [Related]
20. Gonadoblastoma-associated mixed germ cell tumour in 46,XY complete gonadal dysgenesis (Swyer syndrome): analysis of Y chromosomal genotype and OCT3/4 and TSPY expression profile. Ng SB; Yong MH; Knight LA; Lee VK; Nadarajah S; Stoop H; Looijenga LH Histopathology; 2008 Apr; 52(5):644-6. PubMed ID: 18312345 [No Abstract] [Full Text] [Related] [Next] [New Search]